Determining the synergistic effects of complementary medicines on pro-inflammatory cytokines,

确定补充药物对促炎细胞因子的协同作用,

基本信息

  • 批准号:
    nhmrc : 471402
  • 负责人:
  • 金额:
    $ 19.36万
  • 依托单位:
  • 依托单位国家:
    澳大利亚
  • 项目类别:
    NHMRC Strategic Awards
  • 财政年份:
    2008
  • 资助国家:
    澳大利亚
  • 起止时间:
    2008-01-01 至 2011-12-31
  • 项目状态:
    已结题

项目摘要

Diseases like influenza, commonly called ‘the flu’, produce symptoms such as fever, headaches, lethargy and lack of appetite. What most people don’t realise is that it is not the influenza virus that produces these symptoms, but the body’s immune response to the influenza virus. This immune response comes about because the influenza virus stimulates cells to produce molecules called cytokines, and cytokines have many effects in the body, including causing fever and a lack of appetite. In severe infections like those caused by the influenza virus responsible for the pandemic of 1918, and during “bird ‘flu” (H5N1) infections, people die because the immune response becomes overwhelming. Cytokines produced during these sorts of responses are actually very harmful, even though in small amounts they help to kill the virus and cure the infection. Researchers working in this field have likened these severe responses to a “cytokine storm”. This project focusses on finding alternative therapies such as those used in Chinese medicine to prevent a cytokine storm happening, so that if an influenza pandemic occurs these treatments could be quickly made available to everyone. Examples are the Chinese herbs Angelica sinensis and Salvia miltiorrhiza. Recent laboratory studies in New York have shown that both of these herbs have potent cytokine effects, decreasing levels of an inflammatory cytokine known to be associated with death in both malaria and sepsis. Our study aims to closely examine the effects of these Chinese herbs, as well as other commercially available herbal extracts, and traditional combinations of herbs, to find synergies between them that could be used to treat severe influenza infections.
像流行性感冒这样的疾病,通常被称为“流感”,会产生发烧、头痛、嗜睡和食欲不振等症状。大多数人没有意识到的是,产生这些症状的不是流感病毒,而是人体对流感病毒的免疫反应。这种免疫反应是因为流感病毒刺激细胞产生称为细胞因子的分子,而细胞因子在体内有许多作用,包括引起发烧和食欲不振。在严重感染中,例如由1918年大流行的流感病毒引起的感染,以及在“禽流感”(H5 N1)感染期间,人们会因为免疫反应变得压倒性而死亡。在这些反应过程中产生的细胞因子实际上是非常有害的,即使少量它们有助于杀死病毒并治愈感染。在这一领域工作的研究人员将这些严重的反应比作“细胞因子风暴”。该项目的重点是寻找替代疗法,例如中医中使用的疗法,以防止细胞因子风暴的发生,以便如果流感大流行发生,可以迅速向每个人提供这些治疗方法。例子是中草药当归和丹参。最近在纽约的实验室研究表明,这两种草药都具有强效的细胞因子作用,降低了已知与疟疾和败血症死亡相关的炎性细胞因子的水平。我们的研究旨在仔细检查这些中草药,以及其他市售草药提取物和传统草药组合的效果,以发现它们之间的协同作用,可用于治疗严重的流感感染。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Dr Lisa Alleva其他文献

Dr Lisa Alleva的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Dr Lisa Alleva', 18)}}的其他基金

H1NI Trialling agents that could limit influenza disease and improve resistance to secondary infections
H1NI 试验药物可以限制流感疾病并提高对继发感染的抵抗力
  • 批准号:
    nhmrc : 585530
  • 财政年份:
    2009
  • 资助金额:
    $ 19.36万
  • 项目类别:
    NHMRC Strategic Awards

相似海外基金

CAREER: Understanding the Synergistic Effects of Irradiation and Molten Salt Corrosion on NiCr Alloys
职业:了解辐照和熔盐腐蚀对镍铬合金的协同效应
  • 批准号:
    2340019
  • 财政年份:
    2024
  • 资助金额:
    $ 19.36万
  • 项目类别:
    Continuing Grant
Metachronous synergistic effects of preoperative viral therapy and postoperative adjuvant immunotherapy via long-term antitumor immunity
术前病毒治疗和术后辅助免疫治疗通过长期抗肿瘤免疫产生异时协同效应
  • 批准号:
    23K08213
  • 财政年份:
    2023
  • 资助金额:
    $ 19.36万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Synergistic Effects of Stress and Traffic-Related Air Pollution on Cardiovascular Health
压力和交通相关空气污染对心血管健康的协同效应
  • 批准号:
    10560427
  • 财政年份:
    2023
  • 资助金额:
    $ 19.36万
  • 项目类别:
An Investigation of Synergistic Effects of Discipline-based Growth Mindset and Effective Learning Strategies Interventions in Gateway Chemistry Courses
基于学科的成长心态与有效学习策略干预在入门化学课程中的协同效应研究
  • 批准号:
    2235476
  • 财政年份:
    2023
  • 资助金额:
    $ 19.36万
  • 项目类别:
    Standard Grant
An Investigation of Synergistic Effects of Discipline-based Growth Mindset and Effective Learning Strategies Interventions in Gateway Chemistry Courses
基于学科的成长心态与有效学习策略干预在入门化学课程中的协同效应研究
  • 批准号:
    2235477
  • 财政年份:
    2023
  • 资助金额:
    $ 19.36万
  • 项目类别:
    Standard Grant
Mechanisms of synergistic effects on prevention from hypertension by simultaneous intake of kelp and vinegar.
海带与醋同时摄入预防高血压的协同作用机制。
  • 批准号:
    23K10905
  • 财政年份:
    2023
  • 资助金额:
    $ 19.36万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
CAS-SC: Understanding Synergistic Effects of Organic Mixtures for Electrocatalytic Hydrogenation for Fuel Production
CAS-SC:了解有机混合物对燃料生产电催化加氢的协同效应
  • 批准号:
    2320929
  • 财政年份:
    2023
  • 资助金额:
    $ 19.36万
  • 项目类别:
    Standard Grant
Synergistic effects of communal eating and cooking experience: A psychological study on the social significance of cooking persons' intervention in communal eating
公共饮食与烹饪体验的协同效应:烹饪者干预公共饮食社会意义的心理学研究
  • 批准号:
    23K01980
  • 财政年份:
    2023
  • 资助金额:
    $ 19.36万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Synergistic effects of COA-Cl, ethanol and/or nicotine on dopamine depletion in the MPTP mouse model of PD
COA-Cl、乙醇和/或尼古丁对 PD MPTP 小鼠模型中多巴胺消耗的协同作用
  • 批准号:
    23K09766
  • 财政年份:
    2023
  • 资助金额:
    $ 19.36万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Green tea-based nano-enhancer as an adjuvant for amplified efficacy and reduced adverse effects in anti-angiogenic drug treatments
基于绿茶的纳米增强剂作为抗血管生成药物治疗中增强疗效并减少不良反应的佐剂
  • 批准号:
    23K17212
  • 财政年份:
    2023
  • 资助金额:
    $ 19.36万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了